Anika Therapeutics Inc (ANIK)
27.84
+0.25
(+0.91%)
USD |
NASDAQ |
May 06, 16:00
27.90
+0.06
(+0.22%)
After-Hours: 20:00
Anika Therapeutics Free Cash Flow: -7.215M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -7.215M |
September 30, 2023 | -11.06M |
June 30, 2023 | -15.79M |
March 31, 2023 | -4.889M |
December 31, 2022 | -3.077M |
September 30, 2022 | 2.316M |
June 30, 2022 | 2.076M |
March 31, 2022 | 2.907M |
December 31, 2021 | 3.254M |
September 30, 2021 | 2.047M |
June 30, 2021 | 6.863M |
March 31, 2021 | 8.267M |
December 31, 2020 | 11.44M |
September 30, 2020 | 22.05M |
June 30, 2020 | 26.08M |
March 31, 2020 | 27.07M |
December 31, 2019 | 34.18M |
September 30, 2019 | 31.27M |
June 30, 2019 | 31.28M |
March 31, 2019 | 30.64M |
December 31, 2018 | 30.26M |
September 30, 2018 | 24.92M |
June 30, 2018 | 24.80M |
March 31, 2018 | 25.10M |
December 31, 2017 | 31.83M |
Date | Value |
---|---|
September 30, 2017 | 31.99M |
June 30, 2017 | 31.06M |
March 31, 2017 | 22.59M |
December 31, 2016 | 10.43M |
September 30, 2016 | 14.69M |
June 30, 2016 | 14.13M |
March 31, 2016 | 28.58M |
December 31, 2015 | 30.69M |
September 30, 2015 | 35.88M |
June 30, 2015 | 35.02M |
March 31, 2015 | 28.83M |
December 31, 2014 | 38.42M |
September 30, 2014 | 32.10M |
June 30, 2014 | 32.36M |
March 31, 2014 | 32.01M |
December 31, 2013 | 24.72M |
September 30, 2013 | 21.52M |
June 30, 2013 | 16.18M |
March 31, 2013 | 16.99M |
December 31, 2012 | 9.044M |
September 30, 2012 | 11.30M |
June 30, 2012 | 11.93M |
March 31, 2012 | 5.650M |
December 31, 2011 | 8.773M |
September 30, 2011 | 4.714M |
Free Cash Flow Range, Past 5 Years
-15.79M
Minimum
Jun 2023
34.18M
Maximum
Dec 2019
8.899M
Average
3.254M
Median
Dec 2021
Free Cash Flow Benchmarks
The Cooper Companies Inc | 136.00M |
Staar Surgical Co | -3.594M |
OrthoPediatrics Corp | -46.03M |
NexGel Inc | -3.932M |
Innovative Eyewear Inc | -6.018M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | 3.638M |
Cash from Investing (Quarterly) | -1.84M |
Cash from Financing (Quarterly) | 0.342M |
Free Cash Flow Per Share (Quarterly) | 0.1228 |
Free Cash Flow to Equity (Quarterly) | 1.798M |
Free Cash Flow to Firm (Quarterly) | 1.798M |
Free Cash Flow Yield | -1.77% |